Celanese stock: a sharp Q2 rebound still has a softer quarter ahead
CE stock analysis and fair value · bull and bear case
The call: SageNoodle rates Celanese Undervalued: base-case fair value USD 60 against a price of USD 45, 34% above the quote. Q2 improved the near-term earnings picture: sales rose sequentially and adjusted EPS increased to $2.45, with both segments contributing to the rebound.
Celanese stock has a stronger second-quarter earnings run rate, but management expects moderation in Q3. The recovery helps the debt-reduction case; it does not yet settle whether earnings can hold.
Valuation as of 28 Sept 2026 · Quote currency: USD. Latest quote: Fri, 09 Oct 2026 19:16:04 GMT.
Written with AI from the linked sources and reviewed by a SageNoodle editor. How we work.
Latest quote
USD 44.85
At publication
USD 47.09
Fair value
USD 60.00
Upside
+33.8%
P/E at publication
Not available
EV/EBITDA
Not available
FCF yield
0.1%
ROIC -3.7% · Horizon Long term; preliminary scenario valuation based on full-year 2026 adjusted EPS guidance
Why Celanese (CE) stock is mispriced
- 01
Q2 improved the near-term earnings picture: sales rose sequentially and adjusted EPS increased to $2.45, with both segments contributing to the rebound.
- 02
Management’s full-year guide implies roughly $6.00 of adjusted EPS, but its expected Q3 moderation makes the durability of the Q2 level the key valuation question.
- 03
At $47.09, the shares trade below a preliminary $60 base-case estimate, but high debt and weak FY2025 returns make that estimate dependent on execution and a recovery that persists.
What Celanese does and how it makes money
Celanese Corporation (NYSE: CE) makes specialty materials and chemicals through two businesses: Engineered Materials and the Acetyl Chain. Engineered Materials supplies materials used in applications including automotive, medical and electronics; the Acetyl Chain produces acetyl products and sells into a range of industrial and consumer markets. The company describes itself as a global chemicals and specialty materials company serving major industries and consumer applications (Q2 2026 earnings release). Revenue comes from material sales across those segments, with results affected by volumes, selling prices, input costs, plant utilization and product mix. Celanese reported $9.5 billion of net sales for 2025. Its two business segments are Engineered Materials and the Acetyl Chain.
For the financial history and all coverage, see Celanese Corp (CE) company research.
What changed: Q2 sales and adjusted earnings rebounded
Celanese shares are down 1.0% today at $47.09, but the reason for the move is unclear. No verified company announcement dated today has been identified, so the move should not be pinned on a fresh business development. The latest reported results are from the company’s August 4, 2026 second-quarter report: net sales reached $2.8 billion, up 18% sequentially, as volume rose 4% and price rose 14% (Q2 2026 earnings release).
Celanese reported adjusted EPS of $2.45, versus $0.85 in Q1 and $1.43 in Q2 a year earlier. GAAP diluted EPS from continuing operations was $1.15, not $2.45; adjusted EPS is a non-GAAP measure and should not be mistaken for the statutory result. Adjusted EBIT was $470 million, while reported operating profit was $276 million. The gap matters: the recovery is real in the company’s adjusted measure, but the measures answer different questions.
The rebound was broad in sales, though not identical in its drivers. Engineered Materials sales rose 9% sequentially, while Acetyl Chain sales rose 28%, including a 22% sequential increase in price. Celanese attributed the results to pricing and mix in Engineered Materials and pricing, margin opportunities and volume gains in the Western Hemisphere for Acetyl Chain. Those are management’s explanations, not evidence that the pricing environment will last.
Why the rebound does not erase the debt problem
The operating leverage cuts both ways. For the third quarter, management expects adjusted EPS of approximately $1.35 to $1.75, citing moderation in supply-related opportunities, higher Engineered Materials raw-material costs and inventory actions tied to footprint changes. That forecast would mark a step down from Q2’s $2.45. For the full year, Celanese continues to expect approximately $6.00 of adjusted EPS and $700 million to $800 million of free cash flow (Q2 2026 earnings release). Those are guidance figures, not results.
The cash matters because the balance sheet leaves little room for a prolonged earnings stumble. Celanese’s FY2025 metrics show $11.35 billion of net debt, against $0.8 billion of free cash flow. FY2025 revenue fell 7.1% from FY2024; operating margin was -8.2% and ROIC -3.7%. Q2 2026 free cash flow was $140 million, compared with $3 million in Q1, but Celanese said working-capital timing affected the quarter. One improved quarter is welcome; it is not yet a new cash-generation pattern.
Cost cuts could help convert the recovery into something sturdier. Celanese said the Ulsan compounding closure and nylon 6,6 network optimization were completed, while the Lanaken acetate tow facility closure remained planned. The company expects those actions to deliver more than $50 million in annualized fixed-cost savings. That is a forward-looking company estimate, and it depends on completing the remaining work and capturing the savings without harming service or sales.
What the shares might be worth—and what would change the view
There is no prior SageNoodle fair value to carry forward. Our preliminary scenario valuation uses Celanese’s full-year adjusted EPS guide, not an independently forecast GAAP earnings figure. At $47.09, the shares are below our $60 base case, calculated as assumed $6.00 adjusted EPS multiplied by an assumed 10× earnings multiple. This is a transparent shorthand, not a full discounted-cash-flow model: the chosen multiple reflects uncertainty around cyclical earnings and leverage, and the guide itself is management’s forecast.
The bear case is $40: assumed $5.00 adjusted EPS at 8×, if the softer Q3 marks a more persistent earnings setback. The bull case is $78: assumed $6.50 at 12×, if cost savings, pricing and cash generation sustain improvement. The weighted scenario value is $56.60: 35% × $40 + 45% × $60 + 20% × $78. Because the base case is the required snapshot fair value, we use $60 there; the weighted value is a separate probability check, not the snapshot estimate. The $60 base implies about 27% upside from $47.09, but the valuation remains preliminary.
The thesis changes only if the recovery lasts long enough to reduce debt and improve returns—not because the stock drew attention today. The next useful evidence is Q3 adjusted EPS against management’s $1.35–$1.75 range, full-year free cash flow against the $700–$800 million guide, and whether the projected cost savings appear in reported performance. A failure to deliver cash while earnings moderate would undercut the cheap-looking case quickly.
Follow SageNoodle on Google
Celanese revenue, margins and cash flow
Revenue (USD, billions)
Margins (%)
Free cash flow (USD, billions)
Estimated ROIC (%)
Net debt (USD, billions)
Monetary values are in USD; revenue, FCF and net debt are in billions; EPS is per share. Missing values appear as gaps and “Not available.” Source: SEC EDGAR XBRL filings, latest restated values; quarterly cash flow derived from year-to-date figures; Q4 = fiscal year minus nine months. ROIC is NOPAT (21% tax) over debt plus equity.
| Period | Revenue | Gross % | Op % | FCF | EPS | ROIC % | Net debt |
|---|---|---|---|---|---|---|---|
| FY2016 | 5.39 | 26.1 | 17.3 | 0.65 | 6.18 | 13.3 | 2.30 |
| FY2017 | 6.14 | 24.6 | 14.0 | 0.54 | 6.09 | 10.8 | 2.82 |
| FY2018 | 7.16 | 27.6 | 18.6 | 1.22 | 8.91 | 16.6 | 2.92 |
| FY2019 | 6.30 | 25.5 | 13.2 | 1.08 | 6.84 | 11.1 | 2.99 |
| FY2020 | 5.66 | 22.9 | 11.7 | 0.98 | 16.8 | 7.29 | 2.72 |
| FY2021 | 8.54 | 31.4 | 22.8 | 1.29 | 16.9 | 19.4 | 3.19 |
| FY2022 | 9.67 | 24.6 | 14.3 | 1.28 | 17.3 | 5.56 | 12.4 |
| FY2023 | 10.9 | 23.6 | 15.2 | 1.33 | 17.8 | 6.43 | 11.6 |
| FY2024 | 10.3 | 22.8 | -7.01 | 0.53 | -14.1 | -3.22 | 11.6 |
| FY2025 | 9.54 | 20.4 | -8.24 | 0.80 | -10.6 | -3.73 | 11.3 |
What Celanese management has said
Guidance
Direct quote
“Based on these dynamics, we expect third quarter adjusted earnings per share of approximately $1.35 to $1.75.”
Long-term strategy
Paraphrased commentary
The release says completed Ulsan and nylon 6,6 network actions, together with continued progress toward the planned Lanaken closure, are expected to deliver more than $50 million in annualized fixed-cost savings.
Celanese fair value: bear, base and bull scenarios
Dot marks the latest quote of USD 44.85.
Bear
35%USD 40
Direct equity valuation using assumed adjusted EPS multiplied by an assumed price-to-adjusted-earnings multiple.
Equity value USD 4.41B ÷ 0.110B diluted shares
- Adjusted EPS
- $5.00 per share; analyst assumption below management’s approximately $6.00 full-year 2026 guide.
- Multiple
- 8× adjusted EPS; analyst assumption for a weaker earnings and cash-generation outcome.
A weaker-than-guided earnings outcome and limited evidence of durable cash generation keep the multiple low. Leverage makes that shortfall consequential.
Base
45%USD 60
Direct equity valuation using management’s approximately $6.00 full-year adjusted EPS guide and an assumed 10× multiple.
Equity value USD 6.61B ÷ 0.110B diluted shares
- Adjusted EPS
- $6.00 per share; management’s approximate full-year 2026 guide, not a reported result.
- Multiple
- 10× adjusted EPS; analyst assumption reflecting cyclical earnings and elevated leverage.
The company broadly delivers its adjusted EPS guide and starts converting stronger operating performance into cash and debt reduction. The multiple remains restrained because FY2025 returns were weak and Q3 is expected to moderate.
Bull
20%USD 78
Direct equity valuation using assumed adjusted EPS multiplied by an assumed price-to-adjusted-earnings multiple.
Equity value USD 8.60B ÷ 0.110B diluted shares
- Adjusted EPS
- $6.50 per share; analyst assumption above management’s approximately $6.00 full-year 2026 guide.
- Multiple
- 12× adjusted EPS; analyst assumption if earnings recovery and debt reduction improve confidence in durability.
Pricing and cost actions prove more durable than the expected Q3 moderation suggests, and better cash generation reduces the balance-sheet discount.
Celanese (CE) stock: bullish vs bearish case
Bull case
- Q2 sales and adjusted earnings rose sequentially, with improvement in both segments.
- Management expects approximately $700 million to $800 million of full-year 2026 free cash flow, which could support deleveraging if delivered.
- Completed footprint actions and the planned Lanaken closure are expected by Celanese to produce more than $50 million in annualized fixed-cost savings.
Bear case
- Management expects Q3 adjusted EPS to moderate to approximately $1.35–$1.75 from Q2’s $2.45.
- FY2025 revenue declined 7.1%, with negative operating margin and ROIC.
- Net debt of $11.35 billion leaves the equity exposed if earnings or cash conversion disappoint.
- The expected cost savings are forward-looking and include a facility closure that was still planned in the latest release.
Celanese stock risks
| Risk | Severity | Probability | Rationale |
|---|---|---|---|
| Debt and refinancing capacity | High | Medium | Celanese’s FY2025 net debt was $11.35 billion. A sustained earnings or cash-flow shortfall would impede deleveraging and reduce financial flexibility. |
| Cyclical pricing and raw-material pressure | High | High | Management expects moderation in supply-related opportunities and higher raw-material costs in Engineered Materials in Q3. Pricing strength may not persist. |
| Cost-savings delivery | Medium | Medium | Celanese expects more than $50 million of annualized fixed-cost savings from network actions, but the Lanaken closure was still planned in the latest release. |
Celanese catalysts: what could move CE stock
- Q3 2026 results; date not providedNeutral
Q3 results versus company guidance
Celanese expects adjusted EPS of approximately $1.35 to $1.75. Results and cash conversion will test whether Q2’s rebound carries through the expected moderation.
- Full-year 2026; date not providedNeutral
Cash flow and cost-savings delivery
The company’s full-year guide is $700 million to $800 million of free cash flow; the projected annualized savings exceed $50 million. These remain management expectations.
Celanese fair value history
| Period | Fair value | Verdict | Note |
|---|
Celanese news
Celanese stock: common questions
- Is Celanese (CE) stock undervalued or overvalued?
- SageNoodle rates Celanese Undervalued: base-case fair value USD 60 against a price of USD 45, 34% above the quote. Q2 improved the near-term earnings picture: sales rose sequentially and adjusted EPS increased to $2.45, with both segments contributing to the rebound.
- What is Celanese's fair value?
- Bear USD 40 (35% probability, Direct equity valuation using assumed adjusted EPS multiplied by an assumed price-to-adjusted-earnings multiple.); Base USD 60 (45% probability, Direct equity valuation using management’s approximately $6.00 full-year adjusted EPS guide and an assumed 10× multiple.); Bull USD 78 (20% probability, Direct equity valuation using assumed adjusted EPS multiplied by an assumed price-to-adjusted-earnings multiple.). The company broadly delivers its adjusted EPS guide and starts converting stronger operating performance into cash and debt reduction. The multiple remains restrained because FY2025 returns were weak and Q3 is expected to moderate.
- What is the bull case for CE stock?
- Q2 sales and adjusted earnings rose sequentially, with improvement in both segments. Management expects approximately $700 million to $800 million of full-year 2026 free cash flow, which could support deleveraging if delivered. Completed footprint actions and the planned Lanaken closure are expected by Celanese to produce more than $50 million in annualized fixed-cost savings.
- What is the bear case for CE stock?
- Management expects Q3 adjusted EPS to moderate to approximately $1.35–$1.75 from Q2’s $2.45. FY2025 revenue declined 7.1%, with negative operating margin and ROIC. Net debt of $11.35 billion leaves the equity exposed if earnings or cash conversion disappoint.
- What are the biggest risks to Celanese stock?
- Debt and refinancing capacity (High severity): Celanese’s FY2025 net debt was $11.35 billion. A sustained earnings or cash-flow shortfall would impede deleveraging and reduce financial flexibility. Cyclical pricing and raw-material pressure (High severity): Management expects moderation in supply-related opportunities and higher raw-material costs in Engineered Materials in Q3. Pricing strength may not persist. Cost-savings delivery (Medium severity): Celanese expects more than $50 million of annualized fixed-cost savings from network actions, but the Lanaken closure was still planned in the latest release.
- What could move CE stock next?
- Q3 2026 results; date not provided: Q3 results versus company guidance. Celanese expects adjusted EPS of approximately $1.35 to $1.75. Results and cash conversion will test whether Q2’s rebound carries through the expected moderation. Full-year 2026; date not provided: Cash flow and cost-savings delivery. The company’s full-year guide is $700 million to $800 million of free cash flow; the projected annualized savings exceed $50 million. These remain management expectations.
Company reference pages
Browse company filings and market quotes to check the latest information. These pages update over time and are separate from the documents cited in this report.